Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
915.67
684.57
1,059.85
880.65
752.83
624.51
910.13
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
915.67
684.57
1,059.85
880.65
752.83
624.51
910.13
Raw Material Cost
449.42
415.29
496.54
477.35
399.48
349.83
398.15
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
76.48
76.56
64.09
76.61
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
4.56
5.88
16.81
29.60
29.84
43.21
46.61
Selling and Distribution Expenses
343.21
199.56
216.19
155.51
137.76
132.97
246.61
Other Expenses
3.63
3.37
2.22
-7.12
-7.20
-7.35
-8.19
Total Expenditure (Excl Depreciation)
833.44
654.44
751.76
667.69
571.62
516.64
686.12
Operating Profit (PBDIT) excl Other Income
82.2
30.099999999999998
308.09999999999997
213
181.20000000000002
107.89999999999999
224
Other Income
8.87
12.26
16.34
16.92
22.77
14.89
19.57
Operating Profit (PBDIT)
156.18
103.50
383.14
278.52
251.37
170.02
289.10
Interest
4.56
5.88
16.81
29.60
29.84
43.21
46.61
Exceptional Items
0.00
-11.63
-13.17
0.00
-23.06
-22.42
0.00
Gross Profit (PBDT)
466.26
269.27
563.31
403.30
353.35
274.68
511.98
Depreciation
69.33
63.93
60.17
52.59
51.38
51.10
45.63
Profit Before Tax
82.28
22.05
292.99
196.32
147.10
53.28
196.86
Tax
0.61
1.56
39.82
18.12
20.18
9.46
25.15
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
81.67
20.50
253.18
178.20
126.92
43.82
171.71
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
81.67
20.50
253.18
178.20
126.92
43.82
171.71
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
81.67
20.50
253.18
178.20
126.92
43.82
171.71
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
1.0
1.0
1.0
1.0
1.0
0.0
Reserves
1,821.47
1,764.93
2,010.68
1,364.55
1,207.53
1,026.05
1,091.32
Earnings per share (EPS)
0.16
0.04
0.55
0.41
0.29
0.11
0.0
Diluted Earnings per share
0.16
0.04
0.55
0.41
0.29
0.11
0.0
Operating Profit Margin (Excl OI)
8.52%
3.99%
28.93%
23.73%
23.54%
16.66%
24.6%
Gross Profit Margin
16.56%
12.56%
33.32%
28.27%
26.36%
16.71%
26.64%
PAT Margin
8.92%
2.99%
23.89%
20.24%
16.86%
7.02%
18.87%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 33.76% vs -35.41% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 298.54% vs -91.90% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 61.51% vs -75.14% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -22.03% vs -64.88% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Teyi Pharmaceutical Group Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
915.67
0
915.67
Other Operating Income
0.00
0.00
0.00
Total Operating income
915.67
0
915.67
Raw Material Cost
449.42
0
449.42
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
4.56
0
4.56
Selling and Distribution Expenses
343.21
0
343.21
Other Expenses
3.63
0.00
3.63
Total Expenditure (Excl Depreciation)
833.44
0
833.44
Operating Profit (PBDIT) excl Other Income
82.23
0.00
82.23
Other Income
8.87
0
8.87
Operating Profit (PBDIT)
156.18
0
156.18
Interest
4.56
0
4.56
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
466.26
0
466.26
Depreciation
69.33
0
69.33
Profit Before Tax
82.28
0
82.28
Tax
0.61
0
0.61
Provisions and contingencies
0
0
0.00
Profit After Tax
81.67
0
81.67
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
81.67
0
81.67
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
81.67
0
81.67
Equity Capital
0
0
0.00
Face Value
0.00
0
0.00
Reserves
1,821.47
0
1,821.47
Earnings per share (EPS)
0.16
0
0.16
Diluted Earnings per share
0.16
0
0.16
Operating Profit Margin (Excl OI)
8.52%
0%
0.00
8.52%
Gross Profit Margin
16.56%
0%
0.00
16.56%
PAT Margin
8.92%
0%
0.00
8.92%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 91.57 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 33.76% vs -35.41% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 8.17 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 298.54% vs -91.90% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 14.73 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 61.51% vs -75.14% in Dec 2024
Annual - Interest
Interest 0.46 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -22.03% vs -64.88% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.52%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






